{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Asulacrine",
  "nciThesaurus": {
    "casRegistry": "80841-47-0",
    "chebiId": "",
    "chemicalFormula": "C24H24N4O4S",
    "definition": "An amsacrine analogue with antineoplastic properties. Asulacrine inhibits the enzyme topoisomerase ll, thereby blocking DNA replication and RNA and protein synthesis.",
    "fdaUniiCode": "S8P50T62B6",
    "identifier": "C91758",
    "preferredName": "Asulacrine",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C1968",
      "C582"
    ],
    "synonyms": [
      "4-Acridinecarboxamide,9-((2-methoxy-4-((methylsulfonyl)amino)phenyl)amino)-N,5-dimethyl",
      "ASULACRINE",
      "Amsalog",
      "Asulacrine"
    ]
  }
}